The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antirheumatics Pharmaceutical Market Research Report 2025
Synopsis
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
The global Antirheumatics Pharmaceutical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antirheumatics Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antirheumatics Pharmaceutical.
Report Scope
The Antirheumatics Pharmaceutical market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antirheumatics Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antirheumatics Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
Segment by Application
Pharmaceutical Industry
Hospital and Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antirheumatics Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
The global Antirheumatics Pharmaceutical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antirheumatics Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antirheumatics Pharmaceutical.
Report Scope
The Antirheumatics Pharmaceutical market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antirheumatics Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antirheumatics Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
Segment by Application
Pharmaceutical Industry
Hospital and Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antirheumatics Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Steroidal Anti-Inflammatory Drugs
1.2.4 Slow Acting Drug
1.2.5 Immunological Preparation
1.3 Market by Application
1.3.1 Global Antirheumatics Pharmaceutical Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antirheumatics Pharmaceutical Market Perspective (2019-2030)
2.2 Antirheumatics Pharmaceutical Growth Trends by Region
2.2.1 Global Antirheumatics Pharmaceutical Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antirheumatics Pharmaceutical Historic Market Size by Region (2019-2024)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Region (2025-2030)
2.3 Antirheumatics Pharmaceutical Market Dynamics
2.3.1 Antirheumatics Pharmaceutical Industry Trends
2.3.2 Antirheumatics Pharmaceutical Market Drivers
2.3.3 Antirheumatics Pharmaceutical Market Challenges
2.3.4 Antirheumatics Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antirheumatics Pharmaceutical Players by Revenue
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2019-2024)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2019-2024)
3.2 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
3.4 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.4.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2023
3.5 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.7 Date of Enter into Antirheumatics Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antirheumatics Pharmaceutical Breakdown Data by Type
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2019-2024)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2025-2030)
5 Antirheumatics Pharmaceutical Breakdown Data by Application
5.1 Global Antirheumatics Pharmaceutical Historic Market Size by Application (2019-2024)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antirheumatics Pharmaceutical Market Size (2019-2030)
6.2 North America Antirheumatics Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antirheumatics Pharmaceutical Market Size by Country (2019-2024)
6.4 North America Antirheumatics Pharmaceutical Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antirheumatics Pharmaceutical Market Size (2019-2030)
7.2 Europe Antirheumatics Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antirheumatics Pharmaceutical Market Size by Country (2019-2024)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antirheumatics Pharmaceutical Market Size (2019-2030)
8.2 Asia-Pacific Antirheumatics Pharmaceutical Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2019-2024)
8.4 Asia-Pacific Antirheumatics Pharmaceutical Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antirheumatics Pharmaceutical Market Size (2019-2030)
9.2 Latin America Antirheumatics Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antirheumatics Pharmaceutical Market Size by Country (2019-2024)
9.4 Latin America Antirheumatics Pharmaceutical Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antirheumatics Pharmaceutical Market Size (2019-2030)
10.2 Middle East & Africa Antirheumatics Pharmaceutical Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2019-2024)
10.4 Middle East & Africa Antirheumatics Pharmaceutical Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
11.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Antirheumatics Pharmaceutical Introduction
11.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
11.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Detail
11.4.2 Roche Holding AG Business Overview
11.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
11.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.4.5 Roche Holding AG Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Detail
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
11.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.5.5 Novartis International AG Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
11.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
11.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Antirheumatics Pharmaceutical Introduction
11.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.8.5 Merck Recent Development
11.9 UCB S.A.
11.9.1 UCB S.A. Company Detail
11.9.2 UCB S.A. Business Overview
11.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
11.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.9.5 UCB S.A. Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Detail
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
11.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2019-2024)
11.10.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
